MEMPHIS, Tenn.--(BUSINESS WIRE)--Apr. 27, 2016--
GTx, Inc. (NASDAQ: GTXI) today announced that the timing for its first
quarter 2016 financial results press release will be Tuesday, May 10,
2016, prior to the opening of the U.S. stock markets. The Company is not
planning to host a conference call or webcast on that date, but will
continue to provide periodic updates on clinical trial results and other
material company developments as appropriate throughout the remainder of
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical
company dedicated to the discovery, development and commercialization of
small molecules for the treatment of cancer, including treatments for
breast and prostate cancer, and other serious medical conditions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160427005274/en/
Source: GTx, Inc.
Lauren Crosby, 901-271-8622
Denise Powell, 510-703-9491